By Joshua Ang, Postdoctoral Research Fellow, University of York

Aedes aegypti mosquitoes are known vectors of several diseases, including dengue, chikungunya, yellow fever, and Zika, which impact millions of people worldwide each year. The effectiveness of existing insecticide-based methods to control this mosquito is threatened by growing insecticide resistance, underscoring the need to develop new approaches. The advent of CRISPR/Cas9 genome editing has reshaped the research and development landscape of new potential vector control tools, leading researchers to explore novel approaches, such as gene drive technologies.